Skip to main content

INGENIERIA DE LA SINTESIS ENZIMATICA DEL 1,2-DHA-PC Y MEJORA DE SU BIODISPONIBILIDAD PARA LA PREVENCION DE ENFERMEDADES NEURODEGENERATIVAS.

PID2022-137671OB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2022
State Plan 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Acetylcholinesterase inhibition and antioxidant activity of DHA-disubstituted phospholipid

  • García-Quinto, Ernestina
  • Sollecito-Rovella, Sabrina
  • Amador-Luna, Víctor M.
  • Montero, Lidia
  • Fernández-Lorente, Gloria
Docosahexaenoic acid (DHA) is an essential fatty acid for the central nervous system. It plays a crucial role in brain health and the prevention of neurodegenerative diseases, particularly in its phospholipid form, which has greater bioavailability. Previous studies, conducted by our group, enabled the enzymatic synthesis of pure disubstituted DHA phospholipids (1,2-Di-DHA-PC). In the present study, the inhibitory activities of 1,2-Di-DHA-PC on acetylcholinesterase (AChE) and its antioxidant capacity were evaluated. The results showed that 1,2-Di-DHA-PC exhibited significant inhibition of the AChE enzyme. Moreover, 1,2-Di-DHA-PC showed antioxidant capacity compared to ascorbic acid, a natural antioxidant par excellence. These findings highlight the therapeutic potential of 1,2-Di-DHA-PC in the treatment of neurodegenerative diseases and its ability to offer protection against the lipid peroxidation of the neuronal aging process, one of the main drivers of neurodegeneration, suggesting the need for further studies to confirm its clinical applicability., The authors gratefully acknowledge the financial support from the Ministry of Science and Innovation, Spain (Number project No. PID2022-137671OB-I00). The authors are also grateful to Novozymes for generously donating the commercial enzymes. Ernestina García gratefully acknowledges the Spanish National Research Council for his predoctoral contract. Victor M. Amador-Luna acknowledge the financial support from the Spanish Ministry of Universities for the predoctoral contract in the “Formación del Profesorado Universitario” grant (FPU21/00054). L.M. acknowledges the “Ramon y Cajal” grant (RYC2021-033148-I) funded by MCIN/AEI/10.13039/501100011033 and by “European Union NextGenerationEU/PRTR.” Special thanks are due to the FOODOMICS group of CIAL for their collaboration in conducting the biological activity assays., Peer reviewed